Apolipoprotein-D: A novel cellular marker for HGPIN and prostate cancer.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 103, doi. 10.1002/pros.10343
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2004 AND VI 58 AND IP 2
Results: 12
1
2
Use of the Gleason system in international comparisons of prostatic adenocarcinomas in blacks (This article is a U.S. Government work and, as such, is in the public domain in the United States of America.).
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 169, doi. 10.1002/pros.10323
- By:
- Publication type:
- Article
3
Dutasteride, the dual 5αreductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line (All research for this study was performed at the Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, NS, Canada.)
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 130, doi. 10.1002/pros.10340
- By:
- Publication type:
- Article
4
CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 183, doi. 10.1002/pros.10324
- By:
- Publication type:
- Article
5
Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: A study of 93 cases.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 164, doi. 10.1002/pros.10322
- By:
- Publication type:
- Article
6
Response to sublethal heat treatment of prostatic tumor cells and of prostatic tumor infiltrating T-cells.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 109, doi. 10.1002/pros.10314
- By:
- Publication type:
- Article
7
Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 174, doi. 10.1002/pros.10320
- By:
- Publication type:
- Article
8
Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene (The information contained within this article does not necessarily reflect the position or policy of the US government.).
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 200, doi. 10.1002/pros.10319
- By:
- Publication type:
- Article
9
Functional and anatomical effects of hormonally induced experimental prostate growth: A urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 156, doi. 10.1002/pros.10318
- By:
- Publication type:
- Article
10
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 121, doi. 10.1002/pros.10317
- By:
- Publication type:
- Article
11
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate.
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 193, doi. 10.1002/pros.10321
- By:
- Publication type:
- Article
12
Radioimmunotherapy of prostate cancer in human xenografts using monoclonal antibodies specific to prostate specific membrane antigen (PSMA): Studies in nude mice (Shankar Vallabhajosula and Peter M. Smith-Jones contributed equally to this study.).
- Published in:
- Prostate, 2004, v. 58, n. 2, p. 145
- By:
- Publication type:
- Article